Cato Daily Podcast cover image

Would Wider Access to GLP-1s Throttle Addiction?

Cato Daily Podcast

CHAPTER

Exploring the Off-Label Use of GLP-1 Drugs in Addiction Treatment

This chapter explores the careful approach required in using GLP-1 drugs for addiction treatment, focusing on ongoing research related to their effectiveness and safety. It also discusses off-label prescribing and its impacts on patients, emphasizing the need for further clinical trials as these medications gain traction for uses outside traditional diabetes and obesity treatment.

00:00
Transcript
Play full episode

Remember Everything You Learn from Podcasts

Save insights instantly, chat with episodes, and build lasting knowledge - all powered by AI.
App store bannerPlay store banner